Form 8-K - Current report:
SEC Accession No. 0001125345-21-000034
Filing Date
2021-02-25
Accepted
2021-02-25 16:04:38
Documents
16
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20210225.htm   iXBRL 8-K 33456
2 EX-99.1 a8-kq42020exhibit991.htm EX-99.1 84756
8 image1.jpg GRAPHIC 9675
  Complete submission text file 0001125345-21-000034.txt   286927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20210225.xsd EX-101.SCH 2420
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20210225_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20210225_def.xml EX-101.DEF 1641
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20210225_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20210225_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20210225_htm.xml XML 10770
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 21680202
SIC: 2834 Pharmaceutical Preparations